A Randomized, double-blind, placebo-controlled study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) at a dose of 30 mcg/kg-IBW/hr (iNO 30) in subjects at risk of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF) receiving Oxygen Therapy
Nathan, Steve.D., Flaherty, Kevin.R., Glassberg, Marilyn.K., Raghu, Ganesh, Swigris, Jeffrey, Alvarez, Roger, Ettinger, Neil, Loyd, Jim, Fernandes, Peter, Gillies, Hunter, Kim, Bo, Shah, Parag, LancasLanguage:
english
Journal:
Chest
DOI:
10.1016/j.chest.2020.02.016
Date:
February, 2020
File:
PDF, 1.49 MB
english, 2020